Doug Schenkel
Stock Analyst at Wolfe Research
(4.46)
# 353
Out of 4,667 analysts
62
Total ratings
48.89%
Success rate
34.32%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RGEN Repligen | Initiates: Peer Perform | n/a | $138.90 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $4.82 | - | 1 | Nov 14, 2024 | |
| DHR Danaher | Upgrades: Outperform | $285 | $233.10 | +22.27% | 2 | Oct 31, 2024 | |
| BRKR Bruker | Downgrades: Peer Perform | n/a | $53.37 | - | 2 | Sep 30, 2024 | |
| A Agilent Technologies | Downgrades: Peer Perform | n/a | $128.57 | - | 8 | Jun 27, 2024 | |
| QGEN Qiagen | Upgrades: Outperform | $50 | $42.09 | +18.79% | 2 | Jun 27, 2024 | |
| TXG 10x Genomics | Downgrades: Peer Perform | n/a | $13.32 | - | 3 | Jun 27, 2024 | |
| ILMN Illumina | Initiates: Outperform | n/a | $131.68 | - | 5 | Dec 13, 2023 | |
| EXAS Exact Sciences | Initiates: Outperform | n/a | $52.70 | - | 4 | Dec 13, 2023 | |
| TMO Thermo Fisher | Initiates: Outperform | n/a | $512.84 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $15.30 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $111.34 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.72 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $20.14 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $30.68 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $167.88 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $357.77 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.17 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $2.68 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.03 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $21.68 | - | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.56 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.29 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.64 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $64 | $78.04 | -17.99% | 4 | Jun 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $41.11 | - | 1 | Nov 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $4.33 | +315.70% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $30.15 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $266.58 | -66.24% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $11.02 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $176.83 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $75.24 | -78.73% | 2 | Sep 28, 2017 |
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $138.90
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $4.82
Upside: -
Danaher
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $233.10
Upside: +22.27%
Bruker
Sep 30, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $53.37
Upside: -
Agilent Technologies
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $128.57
Upside: -
Qiagen
Jun 27, 2024
Upgrades: Outperform
Price Target: $50
Current: $42.09
Upside: +18.79%
10x Genomics
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $13.32
Upside: -
Illumina
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $131.68
Upside: -
Exact Sciences
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $52.70
Upside: -
Thermo Fisher
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $512.84
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $15.30
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $111.34
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.72
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $20.14
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $30.68
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $167.88
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $357.77
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.17
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $2.68
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.03
Upside: -
Jun 21, 2021
Initiates: Outperform
Price Target: n/a
Current: $21.68
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.56
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.29
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $4.64
Upside: -
Jun 30, 2020
Upgrades: Outperform
Price Target: $64
Current: $78.04
Upside: -17.99%
Nov 26, 2018
Initiates: Outperform
Price Target: n/a
Current: $41.11
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $4.33
Upside: +315.70%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $30.15
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $266.58
Upside: -66.24%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $11.02
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $176.83
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $75.24
Upside: -78.73%